Discover
IKT
Inhibikase Therapeutics, Inc.
1.94
2 x 1.52
2 x 2.45
bid
ask
-
0.09
4.43%
2 @ 04:04 AM
1.94 +0.00 (0.00%)
| Ytd | -5.37% | |
| 1y | -0.51% |
1.91
day range
2.10
1.33
52 week range
2.26
| Open | 2.02 | Prev Close | 2.03 | Low | 1.91 | High | 2.10 | Mkt Cap | 256.14M |
| Vol | 913.99K | Avg Vol | 848.78K | EPS | -0.44 | P/E | N/A | Forward P/E | -11.84 |
| Beta | 1.12 | Short Ratio | 0.17 | Inst. Own | 11.62% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-12 | 50-d Avg | 1.80 | 200-d Avg | 1.71 | 1yr Est | 7.00 |
| Income Statement | |||
| Operating Expenses | 18.22M | ||
| Research and Development Expense | 10.84M | ||
| Selling, General and Administrative Expense | 7.38M | ||
| Operating Income | -18.22M | ||
| Net Income | -16.38M | ||
| Net Income Common Stock | -16.38M | ||
| Net Income Common Stock (USD) | -16.38M | ||
| Consolidated Income | -16.38M | ||
| Earnings per Basic Share | -0.10 | ||
| Earnings per Basic Share (USD) | -0.10 | ||
| Earnings per Diluted Share | -0.10 | ||
| Earning Before Interest & Taxes (EBIT) | -16.38M | ||
| Earning Before Interest & Taxes (USD) | -16.38M | ||
| Weighted Average Shares | 172.31M | ||
| Weighted Average Shares Diluted | 172.31M | ||
| Balance Sheet | |||
| Cash and Equivalents | 49.57M | ||
| Cash and Equivalents (USD) | 49.57M | ||
| Investments | 120.80M | ||
| Investments Current | 120.80M | ||
| Current Assets | 172.18M | ||
| Total Assets | 173.33M | ||
| Current Liabilities | 5.71M | ||
| Total Liabilities | 5.71M | ||
| Accumulated Retained Earnings (Deficit) | -159.06M | ||
| Accumulated Other Comprehensive Income | -26.29K | ||
| Shareholders Equity | 167.62M | ||
| Shareholders Equity (USD) | 167.62M | ||
| Assets Non-Current | 1.16M | ||
| Trade and Non-Trade Payables | 1.59M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 2.90M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -89.65M | ||
| Issuance (Purchase) of Equity Shares | 2.90M | ||
| Net Cash Flow from Investing | -80.48M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -80.48M | ||
| Net Cash Flow from Operations | -12.06M | ||
| Share Based Compensation | 5.56M | ||